Browsing byAuthorMurphy, DG

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 4 to 7 of 7< previous 
Issue DateTitleAuthor(s)
2020-12-16Is Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Cost-effective in Prostate Cancer: An Analysis Informed by the proPSMA Trial.de Feria Cardet, RE; Hofman, MS; Segard, T; Yim, J; Williams, S; Francis, RJ; Frydenberg, M; Lawrentschuk, N; Murphy, DG; De Abreu Lourenco, R
2021-01-11Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partnersSchofield, P; Gough, K; Hyatt, A; White, A; Frydenberg, M; Chambers, S; Gordon, LG; Gardiner, R; Murphy, DG; Cavedon, L; Richards, N; Murphy, B; Quinn, S; Juraskova, I
2023-02-20PRIMARY2: A phase III, multi-centre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer.Buteau, JP; Moon, D; Fahey, MT; Roberts, M; Thompson, J; Murphy, DG; Papa, N; Mitchell, C; Kasivisvanathan, V; Stricker, P; O'Brien, J; Counter, W; Sharma, G; Agrawal, S; Ho, B; Yeung, T; De Abreu Lourenço, R
2018-11-01A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocolHofman, MS; Murphy, DG; Williams, SG; Nzenza, T; Herschtal, A; De Abreu Lourenco, R; Bailey, DL; Budd, R; Hicks, RJ; Francis, RJ; Lawrentschuk, N